Company profile
Poseida Therapeutics, Inc.
A Member of the Roche Group
- Industry
- Biotechnology Research
- Employees
- 78
- Headquarters
- San Diego, California
- Founded
- 2014
- LinkedIn followers
- 44,303
- Office locations
- 1
Poseida Therapeutics, Inc. company summary
Poseida Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in San Diego, California, founded in 2014. On LinkedIn the company has around 78 employees and 44,303 followers. Its listed specialties include Genome Engineering, CAR-T cells, Gene Therapy, Gene Editing, Cell Therapy.
What technology does Poseida Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Poseida Therapeutics, Inc.
Poseida was acquired by Roche in early 2025 and is now part of the Roche Group. Poseida is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing.
Specialties
Where is Poseida Therapeutics, Inc. located?
Poseida Therapeutics, Inc. lists 1 location.
Compare companies similar to Poseida Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Poseida Therapeutics, Inc. poseida.com | Biotechnology Research | 78 | 2014 | San Diego, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Poseida Therapeutics, Inc.
What does Poseida Therapeutics, Inc. do?
Poseida was acquired by Roche in early 2025 and is now part of the Roche Group. Poseida is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing.
How many employees does Poseida Therapeutics, Inc. have?
Poseida Therapeutics, Inc. has around 78 employees on LinkedIn.
Where is Poseida Therapeutics, Inc. headquartered?
Poseida Therapeutics, Inc. is headquartered in San Diego, California.
When was Poseida Therapeutics, Inc. founded?
Poseida Therapeutics, Inc. was founded in 2014.
Build a lead list from companies like Poseida Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.